Biomarin Pharmaceutical Inc $76.74
|Trade Time:||Mar 07 09:46 AM Eastern Daylight Time|
|Change:||-0.47 (-0.61 %)|
Quotes displayed are delayed by 15 minutes. Market data is provided by Xignite
Get BMRN Trend Analysis - it has outperformed the S&P 500 by 4%
|Date||Name||Title||Volume||Trade Price||Holding Change|
|3/03/2014||SPIEGELMAN DANIEL K||EVP, Chief Financial Officer||-8,000||$80.32||-11.07%|
|3/03/2014||SPIEGELMAN DANIEL K||EVP, Chief Financial Officer||8,000||$39.06||12.45%|
|2/20/2014||Davis George Eric||SVP, General Counsel||-20,000||$80.00||-24.80%|
|2/20/2014||Davis George Eric||SVP, General Counsel||20,000||$21.51||32.97%|
|2/20/2014||BIENAIME JEAN JACQUES||Chief Executive Officer||-8,000||$80.00||-14.61%|
BMRN Stock Analysis
- No results found.
Get the four benefits of managed futures as outlined in this booklet.
Learn from Warren Buffett, George Soros and More!
Discover Investing Strategies that will Benefit Every Investor Today!